Back to AL Alphabet Inc.

FULCFULC
Showing 7 of 27 quarters

Position history for ALAlphabet Inc.'s holdings in FULCRUM THERAPEUTICS INC

No. Alphabet exited its FULC (Fulcrum Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 14,262 shares worth $161,303. Alphabet already held FULC in its Q3 2019 13F, the earliest on record, and held it in 26 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$50,915

Total Shares Change

-14,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$7.87
0
2025-Q4
Unchanged
14,262
0.0%
$161,3030.0%$11.34
0
2025-Q3
Unchanged
14,262
0.0%
$131,2100.0%$8.67
0
2025-Q2
Unchanged
14,262
0.0%
$98,1230.0%$7.10
0
2025-Q1
Unchanged
14,262
0.0%
$41,0750.0%$3.01
0
2024-Q4
Unchanged
14,262
0.0%
$67,1740.0%$4.68
0
2024-Q3
Unchanged
14,262
0.0%
$50,9150.0%$3.77
0

Other major holders of FULC: FMR LLC, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used